Heico Shares Analysis - March 2026
US Stocks 2026-03-18 08:44 source ↗

Heico Shares at 8-Month Low Amid Hormuz Strait Disruption

Date: March 17, 2026

Overview

Shares of Heico Corporation (HEI.US), a prominent player in the aerospace and defense sector, have recently fallen to their lowest level since May 2025. This decline is attributed to ongoing concerns regarding the airline industry, particularly in light of geopolitical tensions in the Middle East and escalating jet fuel prices.

Market Conditions

The current market environment suggests a potential decrease in flight operations, which could lead to diminished demand for aircraft repairs and spare parts. This scenario poses a risk to Heico's revenue growth in the medium term. Despite reporting record results in the last quarter, the overall market sentiment has shifted, leading to a repricing of companies involved in the civil aerospace sector.

Stock Performance

Heico's stock has experienced a significant downturn, approximately 20% below its historical peak, marking the largest decline since spring of the previous year. Notably, the commercial segment of Heico has been the primary driver of growth in recent quarters. Investors are currently taking profits amid the uncertain market conditions.

Valuation Metrics

Despite the recent stock decline, Heico continues to command a premium valuation, with a forward 12-month price-to-earnings (P/E) ratio nearing 50. Additionally, its price-to-sales and price-to-book ratios are around 9, indicating that investors still have confidence in the company's long-term prospects.

Technical Analysis

The current drawdown relative to the 200-session exponential moving average (EMA200) is approximately 10%. Historically, such levels have been rare and have often preceded demand-driven rebounds. If the Strait of Hormuz is reopened soon, it could serve as a significant catalyst for Heico's stock recovery. Conversely, if disruptions continue, market caution may persist.

Source: xStation5

Back to US Stocks Email alerts subscription
Informational only. Not investment advice.